Showing results (71-80 of 79) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
The Journal of Investigative Dermatology|September 10, 2016
Adaptive Immunity in Fibrosarcomatous Dermatofibrosarcoma Protuberans and Response to Imatinib TreatmentMarcella Tazzari, Valentina Indio, Barbara Vergani, et al.Cancer Research|January 8, 2014
Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progressionViviana Vallacchi, Elisabetta Vergani, Chiara Camisaschi, et al.Journal for Immunotherapy of Cancer|February 16, 2021
Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patientsVeronica Huber, Lorenza Di Guardo, Luca Lalli, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2012
Limited induction of tumor cross-reactive T cells without a measurable clinical benefit in early melanoma patients vaccinated with human leukocyte antigen class I-modified peptidesPaola Filipazzi, Lorenzo Pilla, Luigi Mariani, et al.Cells|February 10, 2021
The microRNA let-7b-5p Is Negatively Associated with Inflammation and Disease Severity in Multiple SclerosisGeorgia Mandolesi, Francesca Romana Rizzo, Sara Balletta, et al.Journal of Cardiovascular Medicine (Hagerstown, Md.)|December 27, 2021
Predictors of fractional flow reserve/instantaneous wave-free ratio discordance: impact of tailored diagnostic cut-offs on clinical outcomes of deferred lesionsOvidio De Filippo, Guglielmo Gallone, Fabrizio D'Ascenzo, et al.The Lancet. Oncology|July 24, 2019
Pazopanib for treatment of advanced extraskeletal myxoid chondrosarcoma: a multicentre, single-arm, phase 2 trialSilvia Stacchiotti, Stefano Ferrari, Andres Redondo, et al.Oncoimmunology|July 3, 2015
Consensus nomenclature for CD8+ T cell phenotypes in cancerLionel Apetoh, Mark J Smyth, Charles G Drake, et al.Oncotarget|December 25, 2014
Classification of current anticancer immunotherapiesLorenzo Galluzzi, Erika Vacchelli, José-Manuel Bravo-San Pedro, et al.Pageof 8